Verenium Financial Statements
Verenium Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
© 2009 Morningstar, Inc. Financial Data provided by
Verenium Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 69.7 | 46.3 | 49.2 |
| Gross Profit ($ mil.) | 34.5 | 26.5 | 36.3 |
| Operating Income ($ mil.) | -- | -- | -- |
| Total Net Income ($ mil.) | (185.5) | (107.6) | (39.3) |
| Diluted EPS (Net Income) | (34.69) | (23.65) | (10.20) |
Verenium Quarterly Statements
| Quarter Ending Jun 09 | Quarter Ending Mar 09 | Quarter Ending Mar 09 | |
|---|---|---|---|
| Revenue ($ mil.) | 16.3 | 14.4 | 14.4 |
| Gross Profit ($ mil.) | 8.8 | 8.6 | 8.6 |
| Operating Income ($ mil.) | -- | -- | -- |
| Total Net Income ($ mil.) | (20.0) | (4.5) | (4.5) |
| Diluted EPS (Net Income) | (2.64) | 0.60 | 0.60 |
Verenium Stock Quote & Chart
11/09/09 14:20:24 EST •
NASDAQ •
4.16
•
 -0.1300
•
-3.0303 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Verenium Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 0.39 | 0.77 | 7.00 |
| Price/Earnings Ratio | (0.16) | (9.97) | 25.45 |
| Price/Book Ratio | (0.83) | 2.04 | 6.74 |
| Price/Cash Flow Ratio | (0.45) | 6.85 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Verenium Financial Ratios
Verenium Competitive Intelligence
| ADM | Iogen Corporation | Novozymes | |
|---|---|---|---|
| Annual Sales ($ mil.) | 69,207.0 | 56.8 | 1,468.3 |
| Employees | 28,200 | 170 (Estimated) |
4,000 |
| Market Cap ($ mil.) | 20,821.4 | -- | -- |
Competitive Landscape
